123 related articles for article (PubMed ID: 35929287)
1. Multifunctional manganese-containing vaccine delivery system Ca@MnCO
Huang L; Liao Y; Li C; Ma Z; Liu Z
Biomater Adv; 2022 May; 136():212752. PubMed ID: 35929287
[TBL] [Abstract][Full Text] [Related]
2. Development of a Listeria monocytogenes based vaccine against prostate cancer.
Shahabi V; Reyes-Reyes M; Wallecha A; Rivera S; Paterson Y; Maciag P
Cancer Immunol Immunother; 2008 Sep; 57(9):1301-13. PubMed ID: 18273616
[TBL] [Abstract][Full Text] [Related]
3. A listeriolysin O subunit vaccine is protective against Listeria monocytogenes.
Phelps CC; Vadia S; Boyaka PN; Varikuti S; Attia Z; Dubey P; Satoskar AR; Tweten R; Seveau S
Vaccine; 2020 Aug; 38(36):5803-5813. PubMed ID: 32684498
[TBL] [Abstract][Full Text] [Related]
4. High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action.
Kim SH; Castro F; Paterson Y; Gravekamp C
Cancer Res; 2009 Jul; 69(14):5860-6. PubMed ID: 19584282
[TBL] [Abstract][Full Text] [Related]
5. MnO
Song T; Liao Y; Zuo Q; Liu N; Liu Z
J Mater Chem B; 2022 May; 10(18):3474-3490. PubMed ID: 35403638
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.
Sewell DA; Shahabi V; Gunn GR; Pan ZK; Dominiecki ME; Paterson Y
Cancer Res; 2004 Dec; 64(24):8821-5. PubMed ID: 15604239
[TBL] [Abstract][Full Text] [Related]
7. A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection.
Rodriguez-Del Rio E; Marradi M; Calderon-Gonzalez R; Frande-Cabanes E; Penadés S; Petrovsky N; Alvarez-Dominguez C
Vaccine; 2015 Mar; 33(12):1465-73. PubMed ID: 25659269
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy.
Peng X; Treml J; Paterson Y
Cancer Immunol Immunother; 2007 Jun; 56(6):797-806. PubMed ID: 17102978
[TBL] [Abstract][Full Text] [Related]
9. Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse.
Singh R; Dominiecki ME; Jaffee EM; Paterson Y
J Immunol; 2005 Sep; 175(6):3663-73. PubMed ID: 16148111
[TBL] [Abstract][Full Text] [Related]
10. Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella.
Verma NK; Ziegler HK; Wilson M; Khan M; Safley S; Stocker BA; Schoolnik GK
Vaccine; 1995 Feb; 13(2):142-50. PubMed ID: 7625107
[TBL] [Abstract][Full Text] [Related]
11. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.
Gunn GR; Zubair A; Peters C; Pan ZK; Wu TC; Paterson Y
J Immunol; 2001 Dec; 167(11):6471-9. PubMed ID: 11714814
[TBL] [Abstract][Full Text] [Related]
12. Expression of two Listeria monocytogenes antigens (P60 and LLO) in Lactococcus lactis and examination for use as live vaccine vectors.
Bahey-El-Din M; Casey PG; Griffin BT; Gahan CGM
J Med Microbiol; 2010 Aug; 59(Pt 8):904-912. PubMed ID: 20488938
[TBL] [Abstract][Full Text] [Related]
13. Listeria monocytogenes desensitizes immune cells to subsequent Ca2+ signaling via listeriolysin O-induced depletion of intracellular Ca2+ stores.
Gekara NO; Groebe L; Viegas N; Weiss S
Infect Immun; 2008 Feb; 76(2):857-62. PubMed ID: 18056478
[TBL] [Abstract][Full Text] [Related]
14. Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines.
Sun R; Liu Y
Hum Vaccin Immunother; 2013 May; 9(5):1058-68. PubMed ID: 23399758
[TBL] [Abstract][Full Text] [Related]
15. Antilisterial immunity includes specificity to listeriolysin O (LLO) and non-LLO-derived determinants.
Bouwer HG; Gibbins BL; Jones S; Hinrichs DJ
Infect Immun; 1994 Mar; 62(3):1039-45. PubMed ID: 7509313
[TBL] [Abstract][Full Text] [Related]
16. Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus anthracis induces CD8-mediated protection against Listeria monocytogenes.
Sirard JC; Fayolle C; de Chastellier C; Mock M; Leclerc C; Berche P
J Immunol; 1997 Nov; 159(9):4435-43. PubMed ID: 9379042
[TBL] [Abstract][Full Text] [Related]
17. Listeria monocytogenes-derived listeriolysin O has pathogen-associated molecular pattern-like properties independent of its hemolytic ability.
Wallecha A; Wood L; Pan ZK; Maciag PC; Shahabi V; Paterson Y
Clin Vaccine Immunol; 2013 Jan; 20(1):77-84. PubMed ID: 23136118
[TBL] [Abstract][Full Text] [Related]
18. A Novel Role of
Vdovikova S; Luhr M; Szalai P; Nygård Skalman L; Francis MK; Lundmark R; Engedal N; Johansson J; Wai SN
Front Cell Infect Microbiol; 2017; 7():154. PubMed ID: 28516064
[TBL] [Abstract][Full Text] [Related]
19. Mucosal vaccine using CTL epitope-pulsed dendritic cell confers protection for intracellular pathogen.
Ozawa Y; Suda T; Nagata T; Hashimoto D; Nakamura Y; Enomoto N; Inui N; Koide Y; Nakamura H; Chida K
Am J Respir Cell Mol Biol; 2009 Oct; 41(4):440-8. PubMed ID: 19202004
[TBL] [Abstract][Full Text] [Related]
20. Listeriolysin O-dependent bacterial entry into the cytoplasm is required for calpain activation and interleukin-1 alpha secretion in macrophages infected with Listeria monocytogenes.
Dewamitta SR; Nomura T; Kawamura I; Hara H; Tsuchiya K; Kurenuma T; Shen Y; Daim S; Yamamoto T; Qu H; Sakai S; Xu Y; Mitsuyama M
Infect Immun; 2010 May; 78(5):1884-94. PubMed ID: 20194588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
